Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Antithrombotic Therapy in Cardiac Patients Requiring Revascularization

NCT03889574 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT03889574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Antithrombotic Therapy in Cardiac Patients Requiring Revascularization
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
February 26, 2019
Completion date
June 27, 2019
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease